
Doximity (NYSE:DOCS) added ~8% in the premarket on Friday after the company posted better-than-expected financials for Q1 fiscal 2026 and announced the acquisition of Pathway Medical, a Canadian startup focused on AI and evidence-based clinical reference.
The San Francisco, California-headquartered online